Citigroup
LGND icon

Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History

Citigroup’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,099
Closed -$627K – 6907
2020
Q4 		$627K Buy
10,099
+481
+5% +$27.4K ﹤0.01% 4004
2020
Q3 		$572K Sell
9,618
-8,977
-48% -$613K ﹤0.01% 3741
2020
Q2 		$1.3M Buy
18,595
+8,817
+90% +$559K ﹤0.01% 3272
2020
Q1 		$444K Sell
9,778
-34,144
-78% -$1.94M ﹤0.01% 3976
2019
Q4 		$2.86M Buy
43,922
+13,465
+44% +$900K ﹤0.01% 2600
2019
Q3 		$1.89M Buy
30,457
+14,267
+88% +$896K ﹤0.01% 2932
2019
Q2 		$1.15M Sell
16,190
-14,908
-48% -$1.1M ﹤0.01% 3452
2019
Q1 		$2.44M Buy
31,098
+23,243
+296% +$1.76M ﹤0.01% 2466
2018
Q4 		$665K Sell
7,855
-641
-8% -$68.3K ﹤0.01% 3827
2018
Q3 		$1.46M Buy
8,496
+7,374
+657% +$1.11M ﹤0.01% 3076
2018
Q2 		$145K Sell
1,122
-5,611
-83% -$626K ﹤0.01% 5372
2018
Q1 		$694K Sell
6,733
-3,847
-36% -$380K ﹤0.01% 3635
2017
Q4 		$904K Sell
10,580
-2,084
-16% -$181K ﹤0.01% 3432
2017
Q3 		$1.08M Buy
12,664
+11,061
+690% +$876K ﹤0.01% 3286
2017
Q2 		$121K Sell
1,603
-2,405
-60% -$168K ﹤0.01% 5198
2017
Q1 		$265K Sell
4,008
-12,022
-75% -$791K ﹤0.01% 4427
2016
Q4 		$1.02M Buy
16,030
+14,748
+1,150% +$931K ﹤0.01% 3675
2016
Q3 		$82K Buy
+1,282
New +$94.1K ﹤0.01% 5333

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Citigroup's LGND Position: Q1 2026 in Review

Citigroup increased its Ligand Pharmaceuticals (LGND) stake by 18% in Q1 2026, buying an estimated $653K and bringing the position to 21,594 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Citigroup first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.61M in Q4 2016. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Citigroup held 21,594 shares of Ligand Pharmaceuticals worth $4.31M as of Q1 2026.
  • Citigroup bought 3,302 Ligand Pharmaceuticals shares in Q1 2026, an estimated $653K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2081 holding.
  • Citigroup first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Ligand Pharmaceuticals position peaked at $8.61M in Q4 2016.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.